This is a limited company view. Sign up for a Free Trial to see everything.

VistaGen, a biotech company, applies human pluripotent stem cell tech for drug rescue, predictive toxicology and drug metabolism screening.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Bay Area

Founded

1998

Employees

14

Stage

Public

Total funding

$41M

Last funding

5 years ago

Acquisitions

0

Growth score

-4

Mindshare score

-7

Scoring

Deals

$36.0M Post IPO Equity

Apr 10, 2013

$500.0K Debt

Mar 7, 2012

$3.8M Venture

Montaur Capital Partners

Aug 10, 2007

Employee Growth

Use VistaGen Therapeutics's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use VistaGen Therapeutics's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Project leader & Senior Scientist II
Business Manager
Senior Scientist II, Project Leader, Hepatocyte Biology

Similar Companies

Chronos Therapeutics

Chronos is a CNS specialist company with a high concentration of expertise in both degenerative and behavioural diseases of the brain and nervous system
Series B|15 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes